Phendimetrazine

Phendimetrazine

SCHEMBL160376

CC1C(c2ccccc2)OCCN1C.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3

The experimentally established mechanism targets of Phendimetrazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 5/20 0.41
SLC6A3 known ✓ Q01959 5/20 0.41
HTR1A P08908 1/20 0.75
KDM4E B2RXH2 1/20 0.43
BLM P54132 1/20 0.43
ALOX15 P16050 1/20 0.43
HTR2B P41595 2/20 0.41
ADRA1A P35348 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
CYP2D6 P10635 4/20 0.38
SLC6A4 P31645 4/20 0.38
KCNH2 Q12809 3/20 0.38
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
ACE P12821 2/20 0.36
MME P08473 1/20 0.36
POLB P06746 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
ADRA2B P18089 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phendimetrazine SCHEMBL29353044 1.00 HTR1A (0.75) HTR1AKDM4EBLMALOX15SLC6A2
Phendimetrazine SCHEMBL15064941 1.00 HTR1A (0.75) HTR1AKDM4EBLMALOX15SLC6A2
Phendimetrazine SCHEMBL29554688 1.00 HTR1A (0.75) HTR1AKDM4EBLMALOX15SLC6A2
Phendimetrazine SCHEMBL160375 1.00 HTR1A (0.75) HTR1AKDM4EBLMALOX15SLC6A2
Phendimetrazine SCHEMBL10613088 0.99 HTR1A (0.73) HTR1AKDM4EBLMALOX15SLC6A2
Phendimetrazine SCHEMBL21603017 0.88 HTR1A (0.57) HTR1AKDM4EBLMALOX15CYP2D6
Phendimetrazine SCHEMBL15064942 0.87 HTR1A (1.00) HTR1ASLC6A2SLC6A3HTR2BADRA1A
Phendimetrazine SCHEMBL49481 0.87 HTR1A (1.00) HTR1ASLC6A2SLC6A3HTR2BADRA1A
Phendimetrazine SCHEMBL344020 0.87 HTR1A (1.00) HTR1ASLC6A2SLC6A3HTR2BADRA1A
Phendimetrazine SCHEMBL598950 0.87 HTR1A (1.00) HTR1ASLC6A2SLC6A3HTR2BADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1010 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122043215-A FPGA aging monitoring method and system based on partition weighting RO array 中科芯磁科技(珠海)有限责任公司 2026-05-15 CN claimed
CN-120145114-A Equipment life prediction method based on multi-level analysis and sequential evaluation method 哈尔滨工业大学 2025-06-13 CN claimed
CN-118629063-B Financial bill analysis method and system based on image recognition technology 深圳广宏盈信网络科技有限公司 2025-04-04 CN claimed
CN-117451054-B Unmanned aerial vehicle high-precision indoor positioning method based on monocular camera, IMU and UWB multi-sensor fusion 合肥工业大学 2025-01-07 CN claimed
CN-117275215-B Urban road congestion space-time prediction method based on graph process neural network 长江空间信息技术工程有限公司(武汉) 2024-11-19 CN claimed
CN-118941719-A Space three-dimensional model data loading method and system and electronic equipment 河北省自然资源信息中心 2024-11-12 CN claimed
CN-118629063-A Financial bill analysis method and system based on image recognition technology 深圳广宏盈信网络科技有限公司 2024-09-10 CN claimed
CN-118484597-A Part manufacturing and assembling outline recommending platform and recommending method based on user feedback 中国商用飞机有限责任公司北京民用飞机技术研究中心 2024-08-13 CN claimed
CN-114590995-B Borosilicate glass articles 肖特股份有限公司 2024-07-12 CN claimed
CN-118213994-A Distributed energy global coordination and collaborative autonomous regulation recovery strategy method and device 国网北京市电力公司 2024-06-18 CN claimed
US-20030119428-A1 Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors SCHERING CORPORATION 2003-06-26 US claimed
US-20020044968-A1 High amount of plasticizer to facilitate plasticization of the matrix material at low shear and then reduced prior to adding the encapsulant to reduce post extrusion GENERAL MILLS, INC. 2002-04-18 US claimed
JP-2002511777-A 2002-04-16 JP claimed
EP-1119345-A1 ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES GENERAL MILLS, INC. (US) 2001-08-01 EP claimed
WO-2000021504-A1 ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES GENERAL MILLS, INC. (US) 2000-04-20 WO claimed
EP-0935523-A4 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GEN MILLS INC (US) 1999-12-29 EP claimed
EP-0935523-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GENERAL MILLS, INC. (US) 1999-08-18 EP claimed
US-5795880-A Method and composition for treating obesity and related disorders in animals comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent LOUISIANA STATE UNIVERSITY MEDICAL CENTER FOUNDATION (US) 1998-08-18 US claimed
WO-1998018610-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES LENGERICH BERNHARD H VAN (US) 1998-05-07 WO claimed
US-5527788-A Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent LOUISIANA STATE UNIV. MEDICAL CENTER FOUNDATION (US) 1996-06-18 US claimed